Skyline Medical Appoints J. Melville Engle and Timothy A. Krochuk to its Board of Directors
11:13 PM October 27, 2016MINNEAPOLIS, Oct. 27, 2016, SKLN, (GLOBE NEWSWIRE) — Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the appointments of Timothy A. Krochuk and J. Melville (“Mel”) Engle to its Board of Directors, effective as of today. These appointments increase the number of Directors to five, all of whom are independent directors. “We are delighted to welcome such talented and experienced professionals as Tim and Mel to the
Read more